Agilon Health (AGL) said on Friday that it received a notice from the New York Stock Exchange that it is no longer in compliance with listing standards, as its average closing price had remained below $1 for 30 consecutive trading days.
The company said the notice has no immediate impact on its listing and its shares will continue to trade during the exchange's cure period.
It added that the notice will not affect its business operations or the US Securities and Exchange Commission reporting.
Agilon said it plans to notify the NYSE by Nov. 19 of its intention to remain listed and expects to pursue a reverse stock split, subject to stockholder approval at its 2026 annual meeting, to regain compliance.
Comments